RxDoctor Payments Data

Vivek Huilgol, MD

Gastroenterology · New Orleans, LANPI 1760426035

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $25,506 of the $36,657 with a category attached, or 69.6%. US Endoscopy accounts for 69.6% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $14,630, 4.2 times the $3,443 reported in 2019. Among gastroenterology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$36,657in general payments, 2019–2025

Across 52 payments — averaging $704.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • US Endoscopy$26K
  • Capsovision, Inc.$10K
  • Olympus America Inc.$258
  • AbbVie$150
  • AstraZeneca$125
  • Gilead$57
  • plus $117 from 4 others
$1,596,024in research payments, 2019–2025

Across 322 payments — averaging $4956.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$1.3M
  • Eli Lilly$227K
  • Bausch Health US, LLC$35K
  • Bristol Myers Squibb$16K
  • Astrazeneca UK Limited$10K

What the payments were for

  • Royalty or licence$25,50670%
  • Consulting fees$10,39228%
  • Food & beverage$7592%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,657 in reported general payments places this provider in the 90th percentile of 254 gastroenterology providers in Louisiana.

See all gastroenterology providers in Louisiana

Medicare billing

Part B allowed, 2024
$17,443
Medicare patients
97
Services billed
156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →